Releasable intraluminal suture to reduce hypotony after Preserflo glaucoma surgery
Official title: Efficacy and Safety of a Releasable Intraluminal Suture Technique to Reduce Hypotony Following Glaucoma Surgery Using the Preserflo Device
Run by Hôpital Privé de la Baie · NCT07531199 · Data updated 2026-11-12
This trial tests a releasable stitch technique to lower the risk of hypotony after glaucoma surgery with the Preserflo device in adults with certain types of glaucoma.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 192 (estimated) |
| Sponsor | Hôpital Privé de la Baie Academic / other |
| Locations | 1 site (Avranches) |
| Status | Recruiting |
| Started | September 17, 2026 |
| Main results expected | December 31, 2028 |
| Study ends | February 28, 2029 |
| Registry record updated | October 2, 2026 |
| Trial ID | NCT07531199 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with primary open-angle, pseudoexfoliative, or pigmentary glaucoma needing glaucoma surgery and meeting conjunctival health and prior treatment criteria.
✕Probably not a fit
Patients without the targeted glaucoma types or who do not meet surgical eligibility or who have exclusion criteria may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates a releasable intraluminal suture method used with the Preserflo glaucoma drainage device. It aims to determine safety and potential to reduce postoperative hypotony while maintaining intraocular pressure control. Eligible participants have open-angle, pseudoexfoliative, or pigmentary glaucoma requiring surgical intervention and meet criteria related to conjunctival health and prior treatment failure or risk of failure. The investigation uses a standard surgical approach with the added releasable suture technique to modulate outflow. Results will inform whether this method can improve outcomes in MIGS/LIGS contexts.
Why it matters
Potential benefit: If successful, patients may experience fewer cases of postoperative hypotony and better overall IOP control after Preserflo surgery.
How similar studies have gone: Preliminary results from similar Preserflo approaches have shown promise for safety and effectiveness in reducing complications.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary open-angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma with an indication for glaucoma surgery (defined as uncontrolled intraocular pressure or worsening of visual fields, despite maximum tolerated medical therapy) and an open iridocorneal angle (trabeculum visible on gonioscopy, Shaffer classification grade 3-4) * Healthy, mobile conjunctiva (without scarring or adhesions). * The indication for glaucoma surgery is defined as uncontrolled IOP or worsening of visual fields despite maximum tolerated medical therapy, and with either a previous failure of trabeculectomy or a risk of failure. * Maximum tolerated medical therapy: 3 or more classes of ocular hypotensive treatment, or fewer if there is an allergy or intolerance to the treatment. Visual field defects must be more severe than -3 dB in mean deviation. Exclusion Criteria: * severe systemic pathologies * other ophtalmic pathologies (except cataract) * previous intraocular surgery (except cataract) * neovascular glaucoma or iris neovascularization * pachymetry \< 490µm or \> 620µm * contraindication to PRESERFLO Microshunt
Where it's running
-
Hôpital Privé de la Baie
Avranches, France Recruiting
Study contacts
- Principal investigator: Ana Miguel, MD — Hôpital Privé de la Baie
- Study coordinator: Marion Mandon, PhD
- Email: mmandon@vivalto-sante.com
- Phone: +33 6 78 27 76 72
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Balance training for people with glaucoma
A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.
-
Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma
In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.
-
Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients
This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.
-
Removing the ripcord from a glaucoma drainage device after 3 months
This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.
-
Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing
This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.
-
Long-Term Results After Ab-interno Trabeculotomy for Glaucoma
This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.